BWP
IMUX icon

Baldwin Wealth Partners’s Immunic IMUX Stock Holding History

Baldwin Wealth Partners’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$3K – 801
2022
Q3 		$3K Hold
100
– – ﹤0.01% 599
2022
Q2 		$3K Hold
100
– – ﹤0.01% 633
2022
Q1 		$11K Hold
100
– – ﹤0.01% 533
2021
Q4 		$10K Hold
100
– – ﹤0.01% 506
2021
Q3 		$9K Hold
100
– – ﹤0.01% 531
2021
Q2 		$12K Hold
100
– – ﹤0.01% 520
2021
Q1 		$16K Hold
100
– – ﹤0.01% 478
2020
Q4 		$15K Hold
100
– – ﹤0.01% 424
2020
Q3 		$19K Buy
+100
New +$16.4K ﹤0.01% 391

Other funds holding IMUX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Baldwin Wealth Partners's IMUX Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Immunic (IMUX) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Baldwin Wealth Partners first reported a position in IMUX in Q3 2020 and held it in 9 quarters. The position peaked at $19K in Q3 2020. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Immunic position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 100 Immunic shares in Q4 2022, an estimated $3K.
  • Baldwin Wealth Partners first reported a position in Immunic in Q3 2020 and held it in 9 quarters.
  • Baldwin Wealth Partners's Immunic position peaked at $19K in Q3 2020.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.